A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Flotetuzumab Expanded Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Status
- RECRUITING
- Phase
- PHASE2
NK Cell Therapy Recurrent/Refractory Elderly AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Diagnosis and Treatment of Periodontal Disease in Patients With AML
- Status
- WITHDRAWN
- Phase
- NA
Haplo Peripheral Blood Sct In GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
- Status
- TERMINATED
- Phase
- PHASE2
Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML
- Status
- RECRUITING
- Phase
- PHASE1
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of MAX-40279 in Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1
Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia
- Status
- WITHDRAWN
- Phase
- PHASE1
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Oligoblastic AML
- Status
- RECRUITING
- Phase
- PHASE2
CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS
- Status
- COMPLETED
- Phase
- PHASE1
Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS
- Status
- UNKNOWN
- Phase
- PHASE1
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Study of APVO436 in Patients With AML or MDS
- Status
- UNKNOWN
- Phase
- PHASE1